Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT03150667
Eligibility Criteria:
Inclusion Criteria:
* Hospital admission with non-emergent ACS qualifying diagnosis: chest pain, unstable angina or NSTEMI
* A decision to prescribe clopidogrel or ticagrelor in addition to aspirin (DAPT-dual antiplatelet therapy) by the attending physician
* A eGFR\< 60 mL/min per 1.73 m.2 (as defined in the EMR or CPRS reported results)
Exclusion Criteria:
* Diagnosis of ST Elevation Myocardial Infarction (STEMI) at admission
* History of intra-cranial hemorrhage
* Bleeding requiring hospitalization, surgery, or transfusion within the past 3 months
* Life expectancy in the opinion of the provider \< 6 months
* Chronic antithrombotic therapy
* Known allergy to clopidogrel or ticagrelor
* Patients on hemodialysis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03150667
Study Brief:
Protocol Section:
NCT03150667